Akero Therapeutics
AKRO
AKRO
239 hedge funds and large institutions have $3.5B invested in Akero Therapeutics in 2025 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 91 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
239
Holders Change
+49
Holders Change %
+25.79%
% of All Funds
3.25%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.18%
New
77
Increased
91
Reduced
49
Closed
26
Calls
$51.2M
Puts
$36.6M
Net Calls
+$14.6M
Net Calls Change
+$13.8M
Top Buyers
1 |
UBS Group
Zurich,
Switzerland
|
+$72.2M |
2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$69.6M |
3 |
![]()
Marshall Wace
London,
United Kingdom
|
+$54M |
4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$50.6M |
5 |
Janus Henderson Group
London,
United Kingdom
|
+$44.2M |